Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BSGM Biosig Technologies	$4.78 -2.8%	$5.81	$0.23 ▼ $14.11	$154.58M	1.65	834,087 shs	377,575 shs
ELMD Electromed	$24.73 +0.8%	$19.89	$15.06 ▼ $35.56	$207.39M	0.38	84,013 shs	79,825 shs
MBOT Microbot Medical	$3.81 -4.8%	$2.87	$0.82 ▼ $4.62	$182.18M	1.15	3.06 million shs	2.50 million shs
MYO Myomo	$1.05 -1.9%	$1.79	$0.92 ▼ $7.17	$40.45M	1.4	1.94 million shs	1.10 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BSGM Biosig Technologies	-2.85%	-7.72%	+5.75%	-10.32%	+1,095.00%
ELMD Electromed	+0.82%	+22.00%	+32.32%	+22.43%	+63.13%
MBOT Microbot Medical	-4.75%	-1.04%	+47.10%	+47.67%	+302.24%
MYO Myomo	-1.87%	-11.02%	-46.70%	-63.29%	-79.92%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BSGM Biosig Technologies	2.2433 of 5 stars	3.5	0.0	2.2	1.7	0.6
ELMD Electromed	3.1645 of 5 stars	3.7	3.0	2.6	1.7	1.3
MBOT Microbot Medical	1.3408 of 5 stars	3.3	1.0	2.2	0.0	0.6
MYO Myomo	3.7165 of 5 stars	3.5	5.0	3.9	2.5	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BSGM Biosig Technologies	3.00	Buy	$10.00	109.21% Upside
ELMD Electromed	3.33	Buy	$36.25	46.58% Upside
MBOT Microbot Medical	2.50	Moderate Buy	$9.00	136.22% Upside
MYO Myomo	3.00	Buy	$8.17	677.78% Upside

Current Analyst Ratings Breakdown

Latest MYO, MBOT, ELMD, and BSGM Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/27/2025	ELMD Electromed	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$36.00
8/27/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$29.00 ➝ $35.00
8/27/2025	ELMD Electromed	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$36.00
8/21/2025	MBOT Microbot Medical	Zacks Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/12/2025	MYO Myomo	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$9.50 ➝ $5.00
7/22/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$29.00
7/21/2025	ELMD Electromed	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
6/26/2025	MYO Myomo	Alliance Global Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
6/23/2025	MYO Myomo	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$10.00 ➝ $8.00
6/6/2025	BSGM Biosig Technologies	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$2.50 ➝ $10.00
6/5/2025	MYO Myomo	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$11.00 ➝ $11.50

(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BSGM Biosig Technologies	$40K	3,754.69	N/A	N/A	($0.11) per share	-43.45
ELMD Electromed	$61.44M	3.38	$0.60 per share	41.36	$5.10 per share	4.85
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$0.67 per share	N/A
MYO Myomo	$32.55M	1.22	N/A	N/A	$0.47 per share	2.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BSGM Biosig Technologies	-$10.33M	N/A	0.00	N/A	N/A	N/A	-5,336.99%	-90.03%	11/13/2025 (Estimated)
ELMD Electromed	$5.15M	$0.79	32.97	∞	N/A	11.34%	15.71%	13.37%	N/A
MBOT Microbot Medical	-$11.44M	-$0.58	N/A	N/A	N/A	N/A	-76.27%	-67.54%	11/12/2025 (Estimated)
MYO Myomo	-$6.18M	-$0.23	N/A	N/A	N/A	-22.87%	-50.87%	-27.00%	11/5/2025 (Estimated)

Latest MYO, MBOT, ELMD, and BSGM Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/15/2025	Q2 2025	BSGM Biosig Technologies	-$0.04	-$0.74	-$0.70	-$0.74	N/A	N/A
8/12/2025	Q2 2025	MBOT Microbot Medical	-$0.08	-$0.10	-$0.02	-$0.10	$1.00 million	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BSGM Biosig Technologies	N/A	N/A	N/A	N/A	N/A
ELMD Electromed	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
MYO Myomo	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BSGM Biosig Technologies	N/A	0.03	0.03
ELMD Electromed	N/A	5.10	4.74
MBOT Microbot Medical	N/A	12.06	12.06
MYO Myomo	0.08	2.39	2.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BSGM Biosig Technologies	7.16%
ELMD Electromed	40.82%
MBOT Microbot Medical	16.30%
MYO Myomo	44.99%

Insider Ownership

Company	Insider Ownership
BSGM Biosig Technologies	24.80%
ELMD Electromed	14.00%
MBOT Microbot Medical	4.74%
MYO Myomo	4.79%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BSGM Biosig Technologies	50	31.42 million	23.63 million	No Data
ELMD Electromed	160	8.39 million	7.36 million	Optionable
MBOT Microbot Medical	20	45.55 million	43.39 million	Optionable
MYO Myomo	90	37.80 million	35.99 million	Not Optionable

MYO, MBOT, ELMD, and BSGM Headlines

Recent News About These Companies

Myomo (NYSEAMERICAN:MYO) Director Thomas Kirk Purchases 50,000 Shares

August 27 at 7:20 AM | insidertrades.com

Myomo (NYSEAMERICAN:MYO) Director Thomas Kirk Acquires 50,000 Shares of Stock

August 20, 2025 | insidertrades.com

Insider Buying: Thomas Kirk Acquires 50,000 Shares of Myomo Inc (MYO)

August 19, 2025 | gurufocus.com

Myomo, Inc. (NYSEAMERICAN:MYO) CEO Paul R. Gudonis Acquires 50,000 Shares

August 19, 2025 | insidertrades.com

Rosalind Advisors, Inc. Increases Stake in Myomo Inc.

August 15, 2025 | gurufocus.com

HC Wainwright Cuts Myomo (NYSEAMERICAN:MYO) Price Target to $5.00

August 13, 2025 | marketbeat.com

MYO Earnings: Guidance Cut Slams Myomo Stock

August 12, 2025 | msn.com

Myomo Inc (MYO) Q2 2025 Earnings Call Highlights: Revenue Surge Amid Rising Costs and Strategic ...

August 12, 2025 | finance.yahoo.com

Why Medical Device Maker Myomo’s Stock Crashed 42% In After-Hours Trading

August 12, 2025 | msn.com

Myomo, Inc. Reports Q2 2025 Financial Results

August 11, 2025 | tipranks.com

Myomo, Inc. (MYO) Q2 2025 Earnings Conference Call Transcript

August 11, 2025 | seekingalpha.com

Myomo, Inc. (MYO) Reports Q2 Loss, Tops Revenue Estimates

August 11, 2025 | zacks.com

Myomo outlines revised 2025 revenue growth target of 23%-29% as lead quality and pipeline conversion shift

August 11, 2025 | msn.com

Myomo Reports Second Quarter 2025 Financial and Operating Results

August 11, 2025 | businesswire.com

Myomo Q2 2025 Earnings Preview

August 11, 2025 | msn.com

Earnings To Watch: Myomo Inc (MYO) Reports Q2 2025 Result

August 10, 2025 | finance.yahoo.com

Insights Ahead: Myomo's Quarterly Earnings

August 9, 2025 | benzinga.com

Myomo to Report Second Quarter 2025 Financial Results on August 11

August 4, 2025 | businesswire.com

Myomo Reveals its $100 Revenue Goal During Investor Day

July 10, 2025 | finance.yahoo.com

Myomo, Inc. (MYO) Latest Press Releases & Corporate News - Yahoo Finance

July 8, 2025 | finance.yahoo.com

Myomo’s 52% decline validates InvestingPro’s January 2024 overvaluation alert

July 5, 2025 | uk.investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MYO, MBOT, ELMD, and BSGM Company Descriptions

Biosig Technologies NASDAQ:BSGM

$4.78 -0.14 (-2.85%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$4.88 +0.11 (+2.20%)

As of 08/29/2025 07:59 PM Eastern

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Electromed NYSE:ELMD

$24.73 +0.20 (+0.82%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$24.70 -0.03 (-0.12%)

As of 08/29/2025 08:00 PM Eastern

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Microbot Medical NASDAQ:MBOT

$3.81 -0.19 (-4.75%)

Closing price 08/29/2025 04:00 PM Eastern

Extended Trading

$3.88 +0.07 (+1.84%)

As of 08/29/2025 07:57 PM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

Myomo NYSEAMERICAN:MYO

$1.05 -0.02 (-1.87%)

Closing price 08/29/2025 04:10 PM Eastern

Extended Trading

$1.05 0.00 (0.00%)

As of 08/29/2025 07:54 PM Eastern

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time